GWAG
MYGN icon

Garrett Wealth Advisory Group’s Myriad Genetics MYGN Stock Holding History

Garrett Wealth Advisory Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-37
Closed -$1.06K – 436
2019
Q3 		$1.06K Buy
+37
New +$1.08K ﹤0.01% 709

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Garrett Wealth Advisory Group's MYGN Position: Q4 2019 in Review

Garrett Wealth Advisory Group sold out of Myriad Genetics (MYGN) in Q4 2019, closing a stake of 37 shares — an estimated $1.06K sold.

Garrett Wealth Advisory Group first reported a position in MYGN in Q3 2019 and held it in 1 quarter. The position peaked at $1.06K in Q3 2019. 227 funds tracked by Wall St. Rank hold MYGN as of Q4 2019.

  • Garrett Wealth Advisory Group reported no remaining Myriad Genetics position as of Q4 2019 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 37 Myriad Genetics shares in Q4 2019, an estimated $1.06K.
  • Garrett Wealth Advisory Group first reported a position in Myriad Genetics in Q3 2019 and held it in 1 quarter.
  • Garrett Wealth Advisory Group's Myriad Genetics position peaked at $1.06K in Q3 2019.
  • 227 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2019.

Based on Garrett Wealth Advisory Group's 13F filing for Q4 2019, filed 28 Jan 2020.